University of California, Los Angeles
Los Angeles, California, 90095, United States
Location status: Recruiting
Location contact
Pamina Gorbach, DrPh, MHS
CONTACT
Valerie El-Alfi, MA
CONTACT
NCT Number: NCT06370780
Despite the widespread availability of effective antiretroviral therapy (ART) in the United States, there remains significant numbers of people living with HIV (PLWH) who fail to achieve and or maintain viral suppression (VS). Disparities persist with the lowest levels of VS among Black individuals, people who use drugs, youth ages 18-24 and people residing in rural areas. Investigators will examine the syndemics underlying these outcomes including substance use, mental health, and barriers to HIV care including racial discrimination, stigma and rural isolation.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Los Angeles, California, 90095, United States
Location status: Recruiting
Pamina Gorbach, DrPh, MHS
CONTACT
Valerie El-Alfi, MA
CONTACT
This study will follow a digital cohort via the REMAIN App. The REMAIN App is adapted from the HealthMPowerment (HMP) platform and tailored to our focus population's unique needs. Digital cohorts, or eCohorts, utilize the flexibility and capacity of the internet to complement traditional approaches to epidemiological research, helping address some of the limitations and challenges associated with conventional cohort studies.
Aim 1 of this study is to recruit and retain a geographically and demographically diverse cohort of PLWH who are sub optimally engaged in care and with a history of, at high risk for, or not currently virally suppressed. Outcomes for this are levels of recruitment and retention to hit the study objectives to enroll 1,000 PLWH at risk for or experiencing VNS and follow them for up to 48 months. Aim 2 is to evaluate longitudinal patterns of care engagement within the cohort by modeling and advanced epidemiologic methods utilizing remote collection of biomarkers of HIV disease (e.g., viral load), online surveys, and brief, frequent app-based "check-ins". Outcomes include both those related to VS and engagement in care as well as engagement in the digital cohort.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Observational cohort only
Time frame: past 3 months
Suppression defined as having less than 200 copies of HIV per milliliter of blood.
Time frame: past 6 months
Adherence of at least 80% to ARV medication
Time frame: one year
Adherence defined as not missing more than 1 HIV care appointment in 1 year
Contact information is provided by the study sponsor or research team.
Pamina Gorbach, DrPh
CONTACT
Valerie El-Alfi, MA
CONTACT
University of California, Los Angeles
Other
Acronym: EPI-LoVE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07737340
Blood-Borne Infections, Communicable Diseases
Ankara, Turkey (Türkiye)
View Trial DetailsNCT07728123
Blood-Borne Infections, Communicable Diseases
Tampa, Florida, United States
View Trial DetailsNCT07473778
Blood-Borne Infections, Communicable Diseases
Birmingham, Alabama, United States
View Trial DetailsNCT07682961
Blood-Borne Infections, Communicable Diseases
Fort Lauderdale, Florida, United States
View Trial Details